These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effect of reperfusion on electrocardiographic and enzymatic infarct size: results of a randomized multicenter study of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) versus intracoronary streptokinase in acute myocardial infarction. Hackworthy RA; Sorensen SG; Fitzpatrick PG; Barry WH; Menlove RL; Rothbard RL; Anderson JL Am Heart J; 1988 Oct; 116(4):903-14. PubMed ID: 3051985 [TBL] [Abstract][Full Text] [Related]
6. The effect of thrombolytic therapy with anisoylated plasminogen streptokinase activator complex on the indicators of myocardial salvage. Buchalter MB; Bourke JP; Jennings K; Adams PC; Kenmure AC; Hah CW; Reid DS Drugs; 1987; 33 Suppl 3():209-15. PubMed ID: 3315593 [TBL] [Abstract][Full Text] [Related]
7. Improved left ventricular function in myocardial infarction following intravenous thrombolytic therapy with acylated plasminogen activator. Ovsyshcher I; Silber H; Hausman MI; Margolis G; Gueron M Angiology; 1990 Feb; 41(2):133-8. PubMed ID: 2407157 [TBL] [Abstract][Full Text] [Related]
8. Serum myoglobin/carbonic anhydrase III ratio as a marker of reperfusion after myocardial infarction. Vuotikka P; Uusimaa P; Niemelä M; Väänänen K; Vuori J; Peuhkurinen K Int J Cardiol; 2003 Oct; 91(2-3):137-44. PubMed ID: 14559123 [TBL] [Abstract][Full Text] [Related]
9. Coronary thrombolysis with intravenous anisoylated plasminogen-streptokinase complex BRL 26921. Been M; de Bono DP; Muir AL; Boulton FE; Hillis WS; Hornung R Br Heart J; 1985 Mar; 53(3):253-9. PubMed ID: 3882107 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of 2 intravenous thrombolytic agents (anisoylated plasminogen streptokinase activator complex versus streptokinase) in patients with acute myocardial infarction. Seabra-Gomes R; Aniceto Silva J; Aleixo A; Real T; Freire I; Torres I; Freitas R; Crespo F Drugs; 1987; 33 Suppl 3():169-74. PubMed ID: 3315586 [TBL] [Abstract][Full Text] [Related]
11. Effects of early thrombolytic therapy (anistreplase versus streptokinase) on enzymatic and electrocardiographic infarct size in acute myocardial infarction. TEAM-2 Investigators. Karagounis L; Moreno F; Menlove RL; Ipsen S; Anderson JL Am J Cardiol; 1991 Oct; 68(9):848-56. PubMed ID: 1927942 [TBL] [Abstract][Full Text] [Related]
12. Acylated plasminogen-streptokinase activator complex: a new approach to thrombolytic therapy. Crabbe SJ; Grimm AM; Hopkins LE Pharmacotherapy; 1990; 10(2):115-26. PubMed ID: 2140889 [TBL] [Abstract][Full Text] [Related]
13. Performance characteristics of creatine kinase-MB isoenzyme measured with an immunoenzymometric and an immunoinhibition assay in acute myocardial infarction with and without thrombolytic therapy. Schiøler V; Thode J; Kjøller E Eur J Clin Chem Clin Biochem; 1992 Jun; 30(6):357-61. PubMed ID: 1511070 [TBL] [Abstract][Full Text] [Related]
14. Variability of thrombolytic coronary reperfusion: an angiographic study of streptokinase and anistreplase. Sorensen SG; Hackworthy RA; Fitzpatrick PG; Menlove R; Anderson JL Clin Cardiol; 1990 Mar; Suppl 5():V15-9; discussion V27-32. PubMed ID: 2182235 [TBL] [Abstract][Full Text] [Related]
15. [Study of survival using anistreplase (Eminase)]. Murray RG Arch Mal Coeur Vaiss; 1990 Feb; 83 Spec No 1():37-40. PubMed ID: 2108645 [TBL] [Abstract][Full Text] [Related]
16. Achievement of coronary artery patency by use of anisoylated plasminogen streptokinase activator complex in acute myocardial infarction. Hillis WS; Hornung RS; Hogg KJ; Hockings N; Burns JM; Dunn FG Drugs; 1987; 33 Suppl 3():117-23. PubMed ID: 3315576 [TBL] [Abstract][Full Text] [Related]
17. New developments in thrombolytic therapy. Collen D; Gold HK Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372 [TBL] [Abstract][Full Text] [Related]
18. Summary of U.S. clinical trials program for evaluation of anistreplase. Anderson JL Clin Cardiol; 1990 Mar; Suppl 5():V33-8; discussion V67-72. PubMed ID: 2182239 [TBL] [Abstract][Full Text] [Related]
19. Time course of serum cardiac enzymes after intracoronary thrombolytic therapy. Creatine kinase, creatine kinase MB isozyme, lactate dehydrogenase, and serum glutamic-oxaloacetic transaminase. Wei JY; Markis JE; Malagold M; Grossman W Arch Intern Med; 1985 Sep; 145(9):1596-600. PubMed ID: 4026489 [TBL] [Abstract][Full Text] [Related]
20. Non-invasive diagnosis of arterial patency after thrombolytic treatment and its relation to prognosis. Norris RM; White HD; Cross DB; Woo KS; Elliott JM; Twigden D; Williams B; Johnson RN Br Heart J; 1993 Jun; 69(6):485-91. PubMed ID: 8343313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]